510(k) K261403
K261403 is an FDA 510(k) premarket notification submitted by Global Life Sciences Solutions USA, LLC for the device "Lipipor NLF1A Infusion Filter, Lipipor NLF2A & NLF2NTA Infusion Filters, Lipipor TNA2A Infusion Filter". The FDA issued a decision of Substantially Equivalent on August 31, 2026. The device falls under product code FPB (Filter, Infusion Line), a Class II device regulated under 21 CFR 880.5440.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 31, 2026
- Date Received
- April 29, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Filter, Infusion Line
- Device Class
- Class II
- Regulation Number
- 880.5440
- Review Panel
- HO
- Submission Type